← All articles

Photo · Gordon More

Responsible innovation in human germline gene editing: Background document to the recommendations of ESHG and ESHRE

Guido de Wert, Björn Heindryckx, Guido Pennings, Angus Clarke, Ursula Eichenlaub-Ritter, Carla van El, Francesca Forzano, Mariëtte Goddijn, Heidi Howard, Dragica Radojković, Emmanuelle Rial‐Sebbag, Wybo Dondorp, Basil C. Tarlatzis, Martina C. Cornel, On behalf of the European Society of Human Genetics and the European Society of Human Reproduction and Embryology · 2018 · European Journal of Human Genetics

Summary. This paper examines responsible innovation in human germline gene editing across Europe. The authors review scientific developments, legal regulations, and ethical considerations for gene editing in basic research, pre-clinical work, and clinical applications. They argue that deontological objections to gene editing lack conviction, while consequentialist concerns about safety require further research. The paper supports adapting regulations to technological progress while addressing ethical and societal concerns.

Read the original

Cite this article

Wert, G. D., Heindryckx, B., Pennings, G., Clarke, A., Eichenlaub-Ritter, U., El, C. V., Forzano, F., Goddijn, M., Howard, H., Radojković, D., Rial‐Sebbag, E., Dondorp, W., Tarlatzis, B. C., Cornel, M. C., & Embryology, O. B. O. T. E. S. O. H. G. A. T. E. S. O. H. R. A.. (2018). Responsible innovation in human germline gene editing: Background document to the recommendations of ESHG and ESHRE. European Journal of Human Genetics. https://doi.org/10.1038/s41431-017-0077-z

Details

DOI
10.1038/s41431-017-0077-z
Countries
Belgium, United Kingdom, Germany, Netherlands, France, Greece
Regions
Europe
Categories
policy, innovation-theory, general-innovation
Added
2026-04-28